Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2004 | 1 |
2006 | 1 |
2023 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
A cancer chemopreventive agent silibinin, targets mitogenic and survival signaling in prostate cancer.
Mutat Res. 2004 Nov 2;555(1-2):21-32. doi: 10.1016/j.mrfmmm.2004.05.017.
Mutat Res. 2004.
PMID: 15476849
Review.
There are many epigenetic variables that affect the biological responses of autocrine, paracrine and endocrine regulatory molecules, which determine the growth and development of different cancers including prostate cancer (PCA). One of the focuses of the cur …
There are many epigenetic variables that affect the biological responses of autocrine, paracrine and endocrine regulatory molecules, which d …
Prostate cancer chemoprevention by silibinin: bench to bedside.
Singh RP, Agarwal R.
Singh RP, et al.
Mol Carcinog. 2006 Jun;45(6):436-42. doi: 10.1002/mc.20223.
Mol Carcinog. 2006.
PMID: 16637061
Review.
Prostate cancer (PCA) is the most invasive malignancy and second leading cause of cancer deaths in American males. One approach to reduce PCA incidence, growth and metastasis is prevention and intervention targeted towards mitogenic and survi …
Prostate cancer (PCA) is the most invasive malignancy and second leading cause of cancer deaths in American males. One …
Item in Clipboard
Cite
Cite